SAN DIEGO, June 02, 2025 -- BioAtla, Inc. (Nasdaq: BCAB) (the “Company”), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics for the...
Art Pappas joins a panel at the 2013 BIO International Convention in Chicago titled, "Money Ball - Winning Venture Strategies."
News | 03. 19. 2013
Art Pappas joins a panel at the 2013 BIO International Convention in Chicago titled, "Money Ball - Winning Venture Strategies."
